{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:56:37Z","timestamp":1649159797857},"reference-count":24,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"3","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>El carcinoma apocrino primario de gl\u00e1ndula sudor\u00edpara es una neoplasia con una muy baja incidencia, que puede representar un reto diagn\u00f3stico, cl\u00ednico e histol\u00f3gico, y un reto terap\u00e9utico local, adyuvante y de la enfermedad avanzada. La edad media de los pacientes es de alrededor de 67 a\u00f1os, y no se ha observado preferencia seg\u00fan el sexo. Se presenta con mayor frecuencia en las axilas y en el cuero cabelludo. Se caracteriza cl\u00ednicamente por un lento crecimiento, aunque puede progresar agresivamente, con compromiso local, ganglionar y metast\u00e1sico, principalmente, pulmonar, hep\u00e1tico y \u00f3seo. El tratamiento recomendado \u2013una vez establecida la histolog\u00eda\u2013 consiste en una resecci\u00f3n local amplia con un margen claro de 1 a 2 cm y linfadenectom\u00eda regional si se detectan ganglios cl\u00ednicamente positivos. El tratamiento adyuvante (radioterapia o quimioterapia) y de la enfermedad avanzada no est\u00e1 claramente establecido.Se presentan dos pacientes de sexo femenino con sospecha inicial de c\u00e1ncer de mama, en quienes se diagnostic\u00f3 finalmente un carcinoma apocrino de gl\u00e1ndula sudor\u00edpara.<\/jats:p>","DOI":"10.7705\/biomedica.5758","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T16:26:36Z","timestamp":1632500796000},"page":"409-419","update-policy":"http:\/\/dx.doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["\u00bfCarcinoma de mama o carcinoma de gl\u00e1ndula sudor\u00edpara? Presentaci\u00f3n de dos casos y an\u00e1lisis de la literatura"],"prefix":"10.7705","volume":"41","author":[{"given":"Mauricio","family":"Luj\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"105092","doi-asserted-by":"crossref","unstructured":"Gatti AP, Tonello L, Pfaffenzeller W, Sav\u00f3ia FO, Goergen DI, De Pieri Coan R, et al. Apocrine sweat gland adenocarcinoma: A rare case report and review. Int J Surg Case Rep. 2017;36:78-81. https:\/\/doi.org\/10.1016\/j.ijscr.2017.04.0","DOI":"10.1016\/j.ijscr.2017.04.029"},{"key":"105093","doi-asserted-by":"crossref","unstructured":"Jandali DB, Ganti A, Al-Khudari S, Tajudeen BA, Revenaugh PC. Prognostic factors and survival outcomes for head and neck cutaneous adnexal cancers. Am J Otolaryngol. 2019;40:110-14. https:\/\/doi.org\/10.1016\/j.amjoto.2018.09.011","DOI":"10.1016\/j.amjoto.2018.09.011"},{"key":"105094","unstructured":"Wauer U, Sellei R, Zoga E, Braun S, Lorenz D. Atypical course of an apocrine sweat gland carcinoma: A very rare malignant tumor and his interdisciplinary treatment. SM J Case Rep. 2017;3:1052."},{"key":"105095","doi-asserted-by":"crossref","unstructured":"Brenn T. Do not break a sweat: Avoiding pitfalls in the diagnosis of sweat gland tumors. Mod Pathol. 2019;33:25-41. https:\/\/doi.org\/10.1038\/s41379-019-0377-7","DOI":"10.1038\/s41379-019-0377-7"},{"key":"105096","doi-asserted-by":"crossref","unstructured":"Ahn CS, Sang\u00fceza OP. Malignant sweat gland tumors. Hematol Oncol Clin North Am. 2019;33:53-71. https:\/\/doi.org\/10.1016\/j.hoc.2018.09.002","DOI":"10.1016\/j.hoc.2018.09.002"},{"key":"105097","doi-asserted-by":"crossref","unstructured":"Paties C, Taccagni GL, Papotti M, Valente G, Zangrandi A, Aloi F. Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer. 1993;71:375-81. https:\/\/doi.org\/10.1002\/1097-0142(19930115)71:2<375::aid-cncr2820710218>3.0.co;2-4","DOI":"10.1002\/1097-0142(19930115)71:2<375::AID-CNCR2820710218>3.0.CO;2-4"},{"key":"105098","doi-asserted-by":"crossref","unstructured":"Le LP, Dias-Santagata D, Pawlak AC, Cosper AK, Nguyen AT, Selim MA, et al. Apocrineeccrine carcinomas: molecular and immunohistochemical analyses. PLoS ONE 2012;7:e47290. https:\/\/doi.org\/10.1371\/journal.pone.0047290","DOI":"10.1371\/journal.pone.0047290"},{"key":"105099","doi-asserted-by":"crossref","unstructured":"Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, et al. A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience. Breast J. 2018;24:1105-8. https:\/\/doi.org\/10.1111\/tbj.13140","DOI":"10.1111\/tbj.13140"},{"key":"105100","doi-asserted-by":"crossref","unstructured":"Zembowicz A, Garc\u00eda CF, Tannous ZS, Mihm MC, Koerner F, Pilch BZ. Endocrine mucinproducing sweat gland carcinoma. Am J Surg Pathol. 2005;29:1330-9. https:\/\/doi.org\/10.1097\/01.pas.0000170348.40057.60","DOI":"10.1097\/01.pas.0000170348.40057.60"},{"key":"105101","doi-asserted-by":"crossref","unstructured":"Agni M, Raven ML, Bowen RC, Laver NV, Chevez-Barrios P, Milman T, et al. An update on endocrine mucin-producing sweat gland carcinoma. Am J Surg Pathol. 2020;44:1005-16. https:\/\/doi.org\/10.1097\/PAS.0000000000001462","DOI":"10.1097\/PAS.0000000000001462"},{"key":"105102","doi-asserted-by":"crossref","unstructured":"Warkel RL. Apocrine gland adenoma and adenocarcinoma of the axilla. Arch Dermatol. 1978;114:198-203. https:\/\/doi.org\/10.1001\/archderm.1978.01640140016004","DOI":"10.1001\/archderm.114.2.198"},{"key":"105103","doi-asserted-by":"crossref","unstructured":"Kazakov DV, McKee PH, Michal M, Kacerovska D. Cutaneous adnexal tumors. First edition. Philadelphia: Lippincott Williams & Wilkins Health; 2012. p. 830.","DOI":"10.1007\/978-0-85729-757-0_9"},{"key":"105104","unstructured":"Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumors. Fourth edition. Lyon: International Agency for Research on Cancer, World Health Organization, International Academy of Pathology; 2018. p. 470."},{"key":"105105","doi-asserted-by":"crossref","unstructured":"Suyama T, Yokoyama M, Nishimura T, Kobayashi K, Katagiri K. Sweat gland carcinoma of the left axilla with disseminated carcinomatosis of the bone marrow. Int J Dermatol. 2020;59:e281-4. https:\/\/doi.org\/10.1111\/ijd.14854","DOI":"10.1111\/ijd.14854"},{"key":"105106","doi-asserted-by":"crossref","unstructured":"Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL. Cutaneous apocrine adenocarcinoma: Defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol. 2012;105:415-9. https:\/\/doi.org\/10.1002\/jso.22023","DOI":"10.1002\/jso.22023"},{"key":"105107","doi-asserted-by":"crossref","unstructured":"Al-Hakami H, Awad BI, Al-Garni M, Al-Maghrabi HA, Al-Shareef N. Apocrine carcinoma of the scalp with neck lymph node metastasis: A case report and review of the literature. J Family Med Prim Care. 2019;8:3758-62 https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_833_19","DOI":"10.4103\/jfmpc.jfmpc_833_19"},{"key":"105108","doi-asserted-by":"crossref","unstructured":"Chamberlain RS, Huber K, White JC, Travaglino-Parda R. Apocrine gland carcinoma of the axilla: Review of the literature and recommendations for treatment. Am J Clin Oncol. 1999;22:131-5. https:\/\/doi.org\/10.1097\/00000421-199904000-00005","DOI":"10.1097\/00000421-199904000-00005"},{"key":"105109","doi-asserted-by":"crossref","unstructured":"Seong MK, Kim EK, Han K, Seol H, Kim HA, Noh WC. Primary apocrine sweat gland carcinomas of the axilla: A report of two cases and a review of the literature. World J Surg Oncol. 2015;13:59. https:\/\/doi.org\/10.1186\/s12957-015-0473-1","DOI":"10.1186\/s12957-015-0473-1"},{"key":"105110","doi-asserted-by":"crossref","unstructured":"Meattini I, Pezzulla D, Saieva C, Bernini M, Orzalesi L, S\u00e1nchez LJ, et al. Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: A case-control study. Clin Breast Cancer. 2018;18:e773-80. https:\/\/doi.org\/10.1016\/j.clbc.2018.02.012","DOI":"10.1016\/j.clbc.2018.02.012"},{"key":"105111","doi-asserted-by":"crossref","unstructured":"Miller DH, Peterson JL, Buskirk SJ, Vallow LA, Ta R, Joseph R, et al. Management of metastatic apocrine hidradenocarcinoma with chemotherapy and radiation. Rare Tumors. 2015;7:13335. https:\/\/doi.org\/10.4081\/rt.2015.6082","DOI":"10.4081\/rt.2015.6082"},{"key":"105112","doi-asserted-by":"crossref","unstructured":"Fujisawa Y, Fujimoto M. Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine. J Dermatol. 2014;41:280-2. https:\/\/doi.org\/10.1111\/1346-8138.12414","DOI":"10.1111\/1346-8138.12414"},{"key":"105113","doi-asserted-by":"crossref","unstructured":"Goldstein R, Stefanato CM, Warbey V, Harries M. Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy. Future Oncol. 2012;8:1199-203. https:\/\/doi.org\/10.2217\/fon.12.94","DOI":"10.2217\/fon.12.94"},{"key":"105114","doi-asserted-by":"crossref","unstructured":"Daniel SJ, Nader R, Kost K, H\u00fcttner I. Facial sweat gland carcinoma metastasizing to neck nodes: A diagnostic and therapeutic challenge. Arch Otolaryngol Head Neck Surg. 2001;127:1495-8. https:\/\/doi.org\/10.1001\/archotol.127.12.1495","DOI":"10.1001\/archotol.127.12.1495"},{"key":"105115","doi-asserted-by":"crossref","unstructured":"Hicham T, Mohammed B, Naoufa H. Primary cutaneous apocrine carcinoma with distant metastasis. J Cancer Clin Trials. 2018;3:2. https:\/\/doi.org\/10.4172\/2577-0535.1000145","DOI":"10.4172\/2577-0535.1000145"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5758\/4849","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5758\/4849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:11:35Z","timestamp":1632510695000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/5758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,22]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.5758","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"2021-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Case presentation","name":"content_type","label":"Content Type"}]}}